Robert Dee Etherington
Amministratore Delegato presso CLENE INC.
Patrimonio netto: 32 726 $ in data 30/04/2024
Posizioni attive di Robert Dee Etherington
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CLENE INC. | Direttore/Membro del Consiglio | 01/01/2020 | - |
| Amministratore Delegato | 01/04/2013 | - | |
| Presidente | 01/04/2013 | - | |
| BioUtah | Direttore/Membro del Consiglio | 01/06/2016 | - |
Clene Nanomedicine, Inc.
 Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT. | Direttore/Membro del Consiglio | - | - |
| Amministratore Delegato | 01/04/2013 | - | |
| Presidente | 01/04/2013 | - | |
| Corsair LLC | Direttore/Membro del Consiglio | 01/03/2018 | - |
Storia della carriera di Robert Dee Etherington
Precedenti posizioni note di Robert Dee Etherington
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Actelion Pharmaceuticals Ltd.
 Actelion Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals Ltd. is a Swiss company that develops and distributes molecular weight drugs. The company is based in Allschwil, Switzerland. | Vendite & Marketing | 01/09/2000 | 01/03/2013 |
Formazione di Robert Dee Etherington
| Brigham Young University | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| Svizzera | 2 |
Posizioni
| Director/Board Member | 4 |
| Chief Executive Officer | 2 |
| President | 2 |
Settori
| Health Technology | 4 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CLENE INC. | Health Technology |
| Aziende private | 4 |
|---|---|
| BioUtah | |
Clene Nanomedicine, Inc.
Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT. | Health Technology |
Actelion Pharmaceuticals Ltd.
Actelion Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals Ltd. is a Swiss company that develops and distributes molecular weight drugs. The company is based in Allschwil, Switzerland. | Health Technology |
| Corsair LLC |